AIDS 2002 Home
 Search For

The Program : Oral Sessions

Session Types
Pl Plenaries
Or Oral Abstracts
Bs Bridging Sessions
Sy Symposia
Db Debates
Lb Late Breaker Sessions
Se Special Events
Sl Senior Lectures

Session Title Session Type Day Start EndVenue
Sunday, July 07, 2002
Conference Opening Ceremony
detail
OrJuly, 0719:3021:00Palau St. Jordi
Thursday, July 08, 2002
PL01 The Global Impact of the HIV/AIDS Epidemic
detail
PlJuly 0808:3010:00Palau St. Jordi
A01 Viral Entry and Chemokines I
detail
OrJuly 0810:3012:00Hall 1:1
B01 Opportunistic Infections
detail
OrJuly 0810:3012:00Hall 2:1
Bs01 Panel Discussion - R&D Priorities: Who Decides?
detail
BsJuly 0810:3012:00Hall 1:2
C01 Interaction Between HIV and STDs
detail
OrJuly 0810:3012:00Hall 1:3
C02 HIV Incidence Measurement: Methods and Applications
detail
OrJuly 0810:3012:00Hall 2:4
D01 HIV Counseling and Testing I
detail
OrJuly 0810:3012:00Hall 2:3
E01 Rethinking Women: Risk and Vulnerability
detail
OrJuly 0810:3012:00Hall 2:5
F01 Prevention of Mother to Child Transmission: Programme Realities
detail
OrJuly 0810:3012:00Hall 5:7
F02 Mitigating the Impact of HIV/AIDS on Children and Adults
detail
OrJuly 0810:3012:00Hall Verdi
G01 Treatment: Strategies for Lowering Prices
detail
OrJuly 0810:3012:00Hall 2:2
Se01 IAS-CTP Satellite on Access to Care
detail
SeJuly 0812:3013:30Hall 2:3
Se02 IAS-WHO Satellite on HIV Drug Resistance
detail
SeJuly 0812:3013:30Hall 2:5
Se03 Ghent IAS-CTP Working Group on HIV in Women and Children
detail
SeJuly 0812:3013:30Hall 2:4
A02 Humoral Immunity to HIV
detail
OrJuly 0814:0015:30Hall 1:1
B02 Hepatitis Virus Co-Infections
detail
OrJuly 0814:0015:30Hall 2:1
Bs02 Ethics in Practice
detail
BsJuly 0814:0015:30Hall 1:2
D02 Harm Reduction Issues
detail
OrJuly 0814:0015:30Hall 2:3
E02 Positively Pregnant: HIV+ Women and Pregnancy
detail
OrJuly 0814:0015:30Hall 2:5
F03 Expanding the Reach of Voluntary Counseling and Testing
detail
OrJuly 0814:0015:30Hall 5:7
G02 Treatment Access Case Studies
detail
OrJuly 0814:0015:30Hall 2:2
SyA01 Regulation of Virus Life Cycle
detail
SyJuly 0814:0015:30Hall Verdi
SyC01 Measuring the Impact of HIV/AIDS on Mortality in High Prevalence Countries
detail
SyJuly 0814:0015:30Hall 1:3
SyD01 What is the Role of STD Control in HIV Prevention? A Synthesis of Data from the Mwanza, Rakai and Masaka Intervention Trials
detail
SyJuly 0814:0015:30Hall 2:4
A03 Vaccines I
detail
OrJuly 0816:0017:30Hall 1:1
B03 Access to Care
detail
OrJuly 0816:0017:30Hall 2:1
B04 Antiretrovival Treatment of Children
detail
OrJuly 0816:0017:30Hall 2:4
Bs03 Opportunities and Challenges in Vaccine Research and Development
detail
BsJuly 0816:0017:30Hall 1:2
C03 HIV and TB
detail
OrJuly 0816:0017:30Hall 1:3
D03 Post-Exposure Prophylaxis (PEP)
detail
OrJuly 0816:0017:30Hall 2:3
E03 Practising Gender: Inequalities, Partners and Relationships
detail
OrJuly 0816:0017:30Hall 2:5
F04 Developing Youth Friendly Programs
detail
OrJuly 0816:0017:30Hall 5:7
G03 Harm Reduction and Policy Implications
detail
OrJuly 0816:0017:30Hall 2:2
SyA02 New Drugs, New Targets
detail
SyJuly 0816:0017:30Hall Verdi
Friday, July 09, 2002
PL02 Prevention Strategies in the XXI Century
detail
PlJuly 0908:3010:00Palau St. Jordi
A04 Viral Entry & Chemokines II
detail
OrJuly 0910:3012:00Hall 1:1
B05 When should you start ARV Therapy?
detail
OrJuly 0910:3012:00Hall 2:1
B06 Mother to Child Transmission (MTCT)
detail
OrJuly 0910:3012:00Hall Verdi
Bs04 Money Matters: Financing the Global Epidemic
detail
BsJuly 0910:3012:00Hall 1:2
C04 HIV, STDs and Risk Behavior on the rise in MSM?
detail
OrJuly 0910:3012:00Hall 1:3
D04 STD Treatment for HIV Prevention
detail
OrJuly 0910:3012:00Hall 2:3
E04 Trans/formations: Gender, Sexuality and AIDS
detail
OrJuly 0910:3012:00Hall 2:5
F05 Enhancing Drug Users Ability to Reduce Harm
detail
OrJuly 0910:3012:00Hall 5:7
G04 Using the Law to Advance Human Rights in AIDS
detail
OrJuly 0910:3012:00Hall 2:2
SyE01 Educating Desire: Case Studies in HIV/AIDS and Sexuality Education
detail
SyJuly 0910:3012:00Hall 2:4
Sl01 Senior Lectures: G Pantaleo, R Gallo, M Essex
detail
SlJuly 0912:3013:30Hall 1:2
Sl02 Senior Lectures: K de Cock, R Marlink, V Terto
detail
SlJuly 0912:3013:30Hall 1:3
Se04 Domestic Response: Global Solutions
detail
SeJuly 0912:3013:30Hall 5:7
A05 Cellular Responses to HIV
detail
OrJuly 0914:0015:30Hall 1:1
B07 Initial Therapy
detail
OrJuly 0914:0015:30Hall 2:1
Bs05 From Basic Science to Real Life: Disturbing Metabolic Disturbances
detail
BsJuly 0914:0015:30Hall 1:2
Bs06 Movement on Microbicides
detail
BsJuly 0914:0015:30Hall Verdi
C05 Molecular Epidemiology and Surveillance of HIV-Subtypes and Resistance
detail
OrJuly 0914:0015:30Hall 1:3
D05 Behavioral and Psychological Risk Factors among MSM
detail
OrJuly 0914:0015:30Hall 2:3
E05 Turning Tricks: Sex Work and HIV/AIDS
detail
OrJuly 0914:0015:30Hall 2:5
F06 Reducing Stigma and Discrimination in Support of Prevention and Care
detail
OrJuly 0914:0015:30Hall 5:7
G05 The Next Generation: Policy Responses for Children Orphaned by and Vulnerable to HIV
detail
OrJuly 0914:0015:30Hall 2:2
SyC02 Population Bridging of HIV: Have Epidemics in IDU Led to Self-sustaining Epidemics in Heterosexuals?
detail
SyJuly 0914:0015:30Hall 2:4
A06 Vaccines: Preclinical to Clinical
detail
OrJuly 0916:0017:30Hall 1:1
Bs07 Tuberculosis & HIV
detail
BsJuly 0916:0017:30Hall 1:2
C06 HIV Behavioral Surveillance around the World
detail
OrJuly 0916:0017:30Hall 1:3
D06 Prevention Technologies Among Women
detail
OrJuly 0916:0017:30Hall 2:3
E06 Man-to-Man: Communities, Identities and HIV/AIDS among Gay and other MSM
detail
OrJuly 0916:0017:30Hall 2:5
F07 Home and Community Care Programs
detail
OrJuly 0916:0017:30Hall Verdi
G06 Capacity and Policy Presequisites for ARV Access
detail
OrJuly 0916:0017:30Hall 2:2
SyB01 Update and Summary of Resistance and Pharmacokinetics
detail
SyJuly 0916:0017:30Hall 2:1
SyF01 Programs to Improve Prevention, Treatment and Care in Latin America and Spanish Speaking Caribbean
detail
SyJuly 0916:0017:30Hall 5:7
SyG01 Making Global Commitment a Reality: Accountability and Funding
detail
SyJuly 0916:0017:30Hall 2:4
Saturday, July 10, 2002
PL03 HIV/AIDS Treatment and Care in the New Century
detail
PlJuly 1008:3010:00Palau St. Jordi
A07 Role of Accessory Genes
detail
OrJuly 1010:3012:00Hall 1:1
B08 Antiretroviral Therapy Issues in Experienced Patients
detail
OrJuly 1010:3012:00Hall 2:1
Bs08 MTCT: Room for Solutions
detail
BsJuly 1010:3012:00Hall 1:2
C07 Surveillance in Resource Poor Settings
detail
OrJuly 1010:3012:00Hall 1:3
D07 Interventions for Youth and Adolescents
detail
OrJuly 1010:3012:00Hall 2:3
E07 Social Fury: Sexual Violence and Masculinity
detail
OrJuly 1010:3012:00Hall 2:5
F08 Integrating HIV with other Health Services
detail
OrJuly 1010:3012:00Hall 5:7
G07 Empowerment PWAs: Involvement from Paper to Action
detail
OrJuly 1010:3012:00Hall 2:2
SyA03 Immune Response to HIV
detail
SyJuly 1010:3012:00Hall 2:4
SyD02 Vaccine Trials
detail
SyJuly 1010:3012:00Hall Verdi
Sl03 Senior Lectures: R N�jera, D Cooper, P Volberding
detail
SlJuly 1012:3013:30Hall 1:2
Sl04 Senior Lectures: H Coovadia, D Des Jarlais, J Sep�lveda
detail
SlJuly 1012:3013:30Hall 1:3
Sl05 Senior Lectures: J Su�rez del Toro, L Fransen, K Mechai Viravaidya
detail
SlJuly 1012:3013:30Hall 5:7
B09 Emerging Toxicity of Antiretoviral Therapy
detail
OrJuly 1014:0015:30Hall 2:1
B10 Rapid and Novel Laboratory Tests
detail
OrJuly 1014:0015:30Hall Verdi
Bs09 Prevention and Treatment: Star-Crossed Lovers?
detail
BsJuly 1014:0015:50Hall 1:2
C08 Modelling and Forecasting the HIV/AIDS Epidemic
detail
OrJuly 1014:0015:30Hall 1:3
D08 Vaginal Microbicides
detail
OrJuly 1014:0015:30Hall 2:3
E08 In the Joint: Prisons and Prisoners
detail
OrJuly 1014:0015:30Hall 2:5
F09 Psychosocial Support Issues in Prevention and Care
detail
OrJuly 1014:0015:30Hall 5:7
G08 Developing and Influencing National Policy
detail
OrJuly 1014:0015:30Hall 2:2
SyA04 New Hope for an HIV Vaccines
detail
SyJuly 1014:0015:30Hall 1:1
SyG02 Private Lives, Public Policy
detail
SyJuly 1014:0015:30Hall 2:4
A08 T-Cell Pathogenesis
detail
OrJuly 1016:0017:30Hall 1:1
Bs10 Addressing Mobile and Migrant Populations
detail
BsJuly 1016:0017:30Hall 1:2
C09 HIV Interactions with Other Viral and Parasitic Infections
detail
OrJuly 1016:0017:30Hall Verdi
D09 Methodologic Issues in Prevention Research
detail
OrJuly 1016:0017:30Hall 2:3
DbB01 ARV: From Guidelines to Real Life
detail
DbJuly 1016:0017:30Hall 2:1
E09 Needles Are Not Just for Threading: New Drug Scenes
detail
OrJuly 1016:0017:30Hall 2:5
F10 The Prevention - Treatment Continuum
detail
OrJuly 1016:0017:30Hall 5:7
G09 Data for Policy
detail
OrJuly 1016:0017:30Hall 2:2
SyC03 Biologic Determinants of HIV Transmission and Disease Progression
detail
SyJuly 1016:0017:30Hall 1:3
SyE02 Brave New World: Thinking Faster than the Epidemic
detail
SyJuly 1016:0017:30Hall 2:4
Sunday, July 11, 2002
PL04 From Science to Action
detail
PlJuly 1108:3010:00Palau St. Jordi
A09 HIV Pathogenesis
detail
OrJuly 1110:3012:00Hall 1:1
B11 Antiretroviral Drug-Resistance
detail
OrJuly 1110:3012:00Hall 2:1
Bs11 Structural Partnerships: Facilitating Care Provision
detail
BsJuly 1110:3012:00Hall 1:2
C10 Determinants of HIV Infection Among IDUs
detail
OrJuly 1110:3012:00Hall 1:3
D10 HIV Counseling and Testing II
detail
OrJuly 1110:3012:00Hall 2:3
E10 Forever Young: Risk, Sexuality and Youth
detail
OrJuly 1110:3012:00Hall 2:5
F11 Caring for Caregivers
detail
OrJuly 1110:3012:00Hall 5:7
G10 Violation and Vulnerability: Public Health and Sexuality
detail
OrJuly 1110:3012:00Hall 2:2
SyD03 Mother to Child Transmission
detail
SyJuly 1110:3012:00Hall Verdi
SyE03 Toward a Political Economy of Access
detail
SyJuly 1110:3012:00Hall 2:4
Sl06 Senior Lectures: B Larder, A Telenti, M Wainberg
detail
SlJuly 1112:3013:30Hall 1:2
Sl07 Senior Lectures: J Curran, P Lamptey, J Sachs
detail
SlJuly 1112:3013:30Hall 1:3
Sl08 Senior Lecture: GIPA - Moving Beyond the Principle
detail
SlJuly 1112:3013:30Hall 5:7
A10 Mechanisms of Viral Resistance
detail
OrJuly 1114:0015:30Hall 1:1
B12 Treatment Interruptions
detail
OrJuly 1114:0015:30Hall 2:1
Bs12 Gender and Sexual Difference
detail
BsJuly 1114:0015:30Hall Verdi
C11 Morbidity and Mortality Patterns in the HAART Era
detail
OrJuly 1114:0015:30Hall 1:3
D11 Effects of HIV Treatment (ART) on HIV Prevention
detail
OrJuly 1114:0015:30Hall 2:3
E11 Acting Out: Culture, Art and Performance
detail
OrJuly 1114:0015:30Hall 2:5
F12 Grappling with Gender Issues in HIV Prevention
detail
OrJuly 1114:0015:30Hall 5:7
F13 Meeting the Prevention Needs of Special Populations
detail
OrJuly 1114:0015:30Hall 2:4
G11 Building Up the Scale and Sustainability of Responses
detail
OrJuly 1114:0015:30Hall 2:2
LB01 Late Breaker
detail
OrJuly 1114:0015:30Hall 1:2
A11 Immune Reconstitution and Immune Based Therapy
detail
OrJuly 1116:0017:30Hall 1:1
Bs13 Stigma, Discrimination and Human Rights
detail
BsJuly 1116:0017:30Hall 1:2
C12 Determinants of HIV Transmission
detail
OrJuly 1116:0017:30Hall 1:3
D12 Social and Individual Determinants of HIV Risk Behavior
detail
OrJuly 1116:0017:30Hall 2:3
DbB02 Update on structured treatment interruption
detail
DbJuly 1116:0017:30Hall 2:1
E12 Tilting at Windmills: Theorizing the Epidemic
detail
OrJuly 1116:0017:30Hall 2:5
F14 Models of Care in Diverse Settings
detail
OrJuly 1116:0017:30Hall Verdi
G12 Workplace Issues
detail
OrJuly 1116:0017:30Hall 2:2
G13 HIV Security and Sustainable Development
detail
OrJuly 1116:0017:30Hall 2:4
LB02 Late Breaker
detail
OrJuly 1116:0017:30Hall 5:7
Monday, July 12, 2002
LB03 Late Breaker
detail
OrJuly 1208:3010:00Palau St. Jordi
Rapporteur Sessions
detail
Or July, 12 10:30 12:00 Palau St. Jordi
Conference Closing Ceremony
detail
Or July, 12 12:00 13:30 Palau St. Jordi

Session Types
Pl Plenaries
Or Oral Abstracts
Bs Bridging Sessions
Sy Symposia
Db Debates
Lb Late Breaker Sessions
Se Special Events
Sl Senior Lectures
 
This site is best viewed at a resolution of [800 X 600] with Internet Explorer 5.5
Copyright © The XIV International AIDS Conference unless otherwise stated.
Any comments or questions can be addressed to the webmaster.